Transtibial Amputation



Transtibial Amputation


COL James R. Ficke, MD

MAJ Daniel J. Stinner, MD


Dr. Ficke or an immediate family member serves as a board member, owner, officer, or committee member of the American Orthopaedic Foot & Ankle Society, the American Academy of Orthopaedic Surgeons, the Society of Military Orthopaedic Surgeons, and the Airlift Research Foundation. Dr. Stinner serves as a board member, owner, officer, or committee member of the Society of Military Orthopaedic Surgeons and the Orthopaedic Trauma Association.



INTRODUCTION

Whether necessitated by trauma, congenital anomaly, tumor, infection, or ischemia, transtibial amputations are commonly performed by orthopaedic surgeons. Burgess et al1 initially described the benefits achieved using a myofascial posterior flap when providing distal coverage of the residual limb. This method was quickly popularized as a result of the successful application of this technique in patients with peripheral vascular disease.1 However, the relatively short posterior flap by today’s standards had its drawbacks, including retraction of the skin incision over the anterior tibia with atrophy of the residual limb, which may result in pressure sores and skin breakdown. This technique was later modified by Assal et al2 to incorporate a longer and thicker posterior flap, with improved fixation of the flap to prevent the migration of the distal soft tissue.

The ideal bone length of the residual limb is 2.5 cm for every 30 cm of body height, which equates to approximately 12.5 to 17.5 cm.3 Although the fibula is commonly sectioned approximately 1 cm proximal to the tibial cut in the standard transtibial amputation, this technique is modified when performing a bone-bridge synostosis of the residual limb.

Ertl4 first reported on his bone-bridging technique in 1949. Since then, there have been various modifications of the procedure but very little available literature demonstrating objective outcomes in patients treated with this surgical technique.5,6 Proponents of this procedure believe that the bone bridge allows the residual limb to be end-bearing or, at a minimum, allows the fibula to contribute in weight bearing, thus distributing the mechanical load of the residual limb. In addition, many supporters feel that it prevents discordant tibiofibular movement, referred to as chopsticking, which may be a source of pain in transtibial amputees.


PATIENT SELECTION

Patients who undergo a transtibial amputation are considered either ischemic or nonischemic. Patients in the nonischemic group are typically younger and healthier, with indications for amputation more likely being due to trauma, tumor, infection, or congenital deformities. Those with ischemic limbs likely have additional comorbidities that need to be assessed before surgical intervention. In addition, successful wound healing in this patient population can be dramatically improved through appropriate surgical technique using a long posterior flap.

When possible, preoperative assessment of healing potential should be performed. Ideally, patients undergoing a transtibial amputation should have an ankle-brachial index greater than 0.5, transcutaneous oxygen saturation on room air greater than 20 to 30 mm Hg, an albumin level greater than 2.5 g/dL, and an absolute lymphocyte count greater than 1,500/µL.7,8 This preoperative assessment is important because 9% to 15% of transtibial amputations ultimately progress to a higher level of limb loss.9,10




Feb 2, 2020 | Posted by in ORTHOPEDIC | Comments Off on Transtibial Amputation

Full access? Get Clinical Tree

Get Clinical Tree app for offline access